Exendin-4-HSA fusion protein (Allist)

N/A

Report date: 2026/04/10 20:01:49

Base Information

Drug NameExendin-4-HSA fusion protein (Allist)
Drug Alias NameN/A
ClassificationBiologics > Protein drugs > Recombinant protein > Fusion protein
Mechanisms of ActionGlucagon-like peptide 1 receptor agonistsSerum albumin modulators
TargetsGlucagon-like peptide 1 receptorSerum albumin
Therapy Area/IndicationsDiabetes Mellitus
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusN/A
Highest Status in ChinaN/A
Originator CompaniesShanghai Allist Pharmaceutical Technology Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesShanghai Allist Pharmaceutical Technology Co Ltd
Active IndicationsN/A
Inactive IndicationsDiabetes Mellitus

Other Information

ATC CodeN/A
Related LinksN/A